North America
Korean beauty products player gets $35m Series D
JJDC, an investment arm of healthcare and consumer goods giant Johnson & Johnson, has led a $35 million Series D round for South Korean online beauty products retailer Memebox.
LP interview: PennSERS
Bryan Lewis, CIO of Pennsylvania State Employees’ Retirement System, discusses accessing Asia, approaches to co-investment, and paring a bloated PE portfolio into a smaller set of strategic relationships
Apax invests $200m in India, US-based Fractal Analytics
Apax Partners has agreed to pay $200 million for a significant minority stake in India and US-based data analytics provider Fractal Analytics.
Baring Asia, Onex to list Clarivate through reverse merger
Baring Private Equity Asia will list Clarivate Analytics – an education business it acquired from Thomson Reuters in conjunction with Onex Corporation – through a merger with a special purpose investment vehicle that trades in New York.
US, China-based Apollomics raises $100m Series B
CMB International Capital, a private equity unit of China Merchants Bank, has led a $100 million Series B round for US and China-based biopharmaceutical developer Apollomics.
SunBridge exits Marketo's Japan JV to Adobe
SunBridge Partners, a US-based VC firm that helps companies access Japan, has exited its position in a Japanese joint venture (JV) with B2B cloud technology provider Marketo to Adobe.
Q&A: Bain Capital's Jonathan Lavine
Asia’s private credit markets are underdeveloped given the size of the regional economy. Jonathan Lavine, co-managing partner of Bain Capital and CIO of Bain Capital Credit, assesses the growth potential
Q&A: Impossible Foods' Nick Halla
Nick Halla became the first employee at Impossible Foods in 2011. Now leading the rollout of the PE-backed company’s plant-based meat substitute products, he explains the strategy for Asia
ChrysCapital acquires US health-tech player
Indian private equity firm ChrysCapital has acquired a majority stake in GeBBS Healthcare Solutions, a California-based developer of enterprise technology for the healthcare sector.
Family offices: Character actors
Family offices are driven by personalities and ideals that cannot be understood as part of an industry pattern. Relationship building is therefore more intimate than transactional
Deal focus: Investors bring new lift to Rocket Lab
Rocket Lab's latest funding round is aimed at helping the New Zealand-founded company grow into new markets and target new business opportunities
Australia's Future Fund leads $140m round for Rocket Lab
Australia’s Future Fund has led a $140 million Series E round for Rocket Lab, a US-based space technology company that operates primarily in New Zealand.
China’s Ucommune gets $200m in Series D round
Chinese co-working space operator Ucommune, formerly named UrWork, has raised $200 million in Series D funding led by All-Stars Investment, with participation from CEC Capital.
Hillhouse co-leads $93m Series B for US biotech firm
Hillhouse Capital and Quan Capital have led a $93 million Series B round for NextCure, a US-based biopharmaceutical company focused on cancer and other diseases.
Q&A: Alaska Permanent Fund Corporation's Yup S. Kim
Yup S. Kim, a senior portfolio manager for private equity and special opportunities, at Alaska Permanent Fund Corporation (APFC) discusses co-investment, accessing Asia, and allocating to permanent capital structures
PE-backed Chinese fashion platform Mogujie files for US IPO
Chinese online shopping and social networking business Mogujie has filed to list in the US. The company's investors include Tencent Holdings, Trustbridge Partners, and Hillhouse Capital.
Fenox launches $20m VC fund with Japan's Sega Sammy
Fenox Venture Capital, a VC firm based in Silicon Valley, has partnered with Japanese entertainment company Sega Sammy Holdings to launch a $20 million fund to invest in advanced technologies globally.
Deal focus: XtalPi takes big pharma into the cloud
China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
US, China-based Terns Pharma secures $80m Series B
Vivo Capital and Orbimed have co-led an $80 million Series B funding round for US and China-based Terns Pharmaceuticals.
Nio Capital, Eight Roads lead Series A for Innovusion
Innovusion, a US-based developer of Lidar technology for autonomous vehicles, has raised a $30 million Series A round led by Eight Roads Ventures China and Nio Capital, a unit of Chinese electric vehicle maker Nio.
SBI-backed Bcause gets funding for Asia crypto push
Bcause, a US-based cryptocurrency services company backed by SBI Holdings has received a commitment of undisclosed size from China Health Checkmate (CHC) to support an Asian expansion.
China looks further afield for deals as US tensions mount - M&A Forum
The escalating Sino-US trade war and tighter US regulatory scrutiny of inbound deals has promoted Chinese buyers to pursue investments in new markets, but they must be prepared to overcome opposition in these destinations as well, the China M&A Forum...
US-China biotech: Troubled transfers
Chinese investment in US biotech – and its ability to import intellectual property for domestic drug development – looks set to be a casualty of worsening relations between the two nations
US regulation: Cold shoulder
New trade legislation in the US is set to have important ramifications for Chinese private equity deal making in a range of data-related technology segments. Macro effects, however, may be muted